Full-Time

Senior Manager

Medical Affairs

Posted on 4/25/2025

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Compensation Overview

$169.3k - $219.1k/yr

+ Bonus + Stock-based long-term incentives

Senior

Company Historically Provides H1B Sponsorship

San Mateo, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • Ideal candidate will have an advanced medical/scientific degree (e.g., MD, PhD, Pharm D, NP/PA) but willing to consider a university degree in life sciences with relevant experience.
  • Experience in at least one of the therapeutic areas that the Liver Disease team is currently engaged in (HBV/HCV/HDV/PBC) is highly desired.
  • Industry experience in Medical Affairs, Clinical Development, or Research or success in a similar role outside of the biotech/pharmaceutical industry is highly desired.
  • Ability to think strategically and translate that strategy into an actionable work plan.
  • Excellent communication skills, including written, verbal, interpersonal, relationship-building and negotiations.
  • Excellent organizational skills to support project planning and execution across multiple activities; anticipate and prioritize workload.
  • Excellent teamwork skills. Organized; attention to detail and able to meet timelines in a fast-paced environment.
  • Excellent analytical and problem-solving skills; demonstrated ability to identify and understand complex issues and problems and identify and query key findings from study data and publications.
  • Experience in developing effective abstracts, manuscripts, posters and slides and preparing presentations at scientific meetings.
  • Must be fully aware and compliant with regulatory and legal (Business Conduct) requirements for clinical trials and other Medical Affairs activities; thorough knowledge of FDA regulations, ICH guidelines and GCPs governing the conduct of clinical trials.
  • Able to work with a high level of autonomy and independence.
  • Bachelor’s degree with 8+ years, Master’s degree with 6 years, or PhD with 2+ years of experience.
Responsibilities
  • Collaborates with country liver medical affairs teams, and other cross functional partners, primarily as a key contributor and knowledge expert in support of the Global Plan of Action for Primary Biliary Cholangitis.
  • Regular communication with the Gilead Medical Scientist Liaison (MSL) team to remain abreast of issues in the field and to provide medical education and support, as needed.
  • Serves as Medical Affairs Representative on GMA development project teams, as assigned.
  • Provides medical and scientific input on Independent Medical Education and Grant applications.
  • Create, revise and maintain Medical Affairs slide decks and other medical education material.
  • Serve as an educational resource to both medical and commercial disease and product training.
  • Works with Executive and Senior Director, and Associate Director/Director on development of a variety of projects, providing independent thought and initiative in the further development of specific projects and ensuing presentations and reports.
  • Manages projects to completion, anticipating obstacles and difficulties that may arise, resolving them in a collaborative manner and providing updates to relevant partners.
  • Attends scientific conferences and helps coordinate medical affairs activities at conferences and may present to external audience.
  • Responsible for the development and execution of projects that will provide more extensive background, additional data/answers to questions in response to issues relative to scientific or data needs.
  • Collaborates with Executive and Senior Directors to develop PBC Plan of Action and ensure alignment of team activities.
  • Other activities, as assigned, to support GMA PBC and Liver Disease.

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company focuses on extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead stands out from its competitors by investing heavily in R&D and forming strategic partnerships, such as with SAP Ariba, to improve its supply chain and ensure sustainable practices. The company's goal is to enhance health equity and access to care, working with communities globally to remove barriers to healthcare and make its medicines available to those in need.

Company Size

10,001+

Company Stage

IPO

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Gilead's $32 billion U.S. investment will create over 3,000 jobs by 2028.
  • The reformulation of lenacapavir offers long-acting HIV prevention, improving patient adherence.
  • Gilead's top five ranking in the Most JUST list highlights its corporate responsibility.

What critics are saying

  • A $202 million settlement for legal violations may damage Gilead's reputation.
  • Layoffs of 150 employees, including senior management, could disrupt company operations.
  • AI-driven drug discovery companies pose a competitive threat to Gilead's traditional R&D.

What makes Gilead Sciences unique

  • Gilead focuses on innovative medicines for unmet needs like HIV/AIDS and liver diseases.
  • The company invests heavily in R&D to maintain a robust pipeline of new treatments.
  • Gilead's partnerships enhance product offerings and expand market reach globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Company News

Fierce Pharma
May 8th, 2025
Gilead tees up $11B in new US manufacturing, R&D investments

This time it's Gilead coming to the table with a fresh $11 billion in hand to spend across its manufacturing and research centers in the U.S.

Gilead Sciences
May 7th, 2025
Gilead U.S. Investment to Create $43 Billion in Value to U.S. Economy

Gilead to invest $32 billion in U.S. manufacturing and R&D through 2030 and create more than 3,000 direct and indirect jobs by 2028

Constantine Cannon
May 5th, 2025
Gilead Pays $202M to Settle False Claims Act Kickback Charges

On April 29, the Department of Justice (DOJ) announced that California-based pharmaceutical giant Gilead Sciences agreed to pay $202 million to settle charges of violating the False Claims Act and Anti-Kickback Statute.

Financial Modeling Prep
May 2nd, 2025
Amgen Inc. (NASDAQ:AMGN) Surpasses Earnings and Sales Estimates in Q1 2025

Amgen competes with other biotech giants like Gilead Sciences and Biogen.

SFist
Apr 2nd, 2025
April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Foster City-based HIV drug company Gilead Sciences is laying off nearly 150 people, and the job cuts are significant among senior members of the company's management.

INACTIVE